0.7634

0.53% -0.0041

Ironwood Pharmaceuticals Inc (IRWD)

Overview News Price History Option Chain Financials Discussions Forecast

Ironwood Pharmaceuticals Inc stock is traded at $0.7634, with a volume of 818.23K. It is down -0.53% in the last 24 hours and up +8.81% over the past month. Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Previous Close:

$0.7675

Open:

$0.7642

24h Volume:

818.23K

Relative Volume:

0.30

Market Cap:

$123.53M

Revenue:

$400.57M

Net Income/Loss:

$9.21M

P/E Ratio:

19.08

EPS:

0.04

Net Cash Flow:

$146.36M

1W Performance:

+3.43%

1M Performance:

+8.81%

6M Performance:

-79.86%

1Y Performance:

-88.64%

1-Day Range:

$0.7501

$0.7993

1-Week Range:

$0.6701

$0.82

52-Week Range:

$0.5271

$7.105

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name

Ironwood Pharmaceuticals Inc

Sector

Healthcare (1161)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

617-621-7722

Address

100 SUMMER STREET, SUITE 2300, BOSTON, MA

Employee

253

Twitter

@ironwoodpharma

Next Earnings Date

2025-02-21

Latest SEC Filings

IRWD's Discussions on Twitter

Compare IRWD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IRWD Ironwood Pharmaceuticals Inc	0.7634	119.44M	400.57M	9.21M	146.36M	0.04
ZTS Zoetis Inc	147.37	69.30B	9.29B	2.52B	2.28B	5.57
TAK Takeda Pharmaceutical Co Adr	14.44	47.50B	30.08B	710.16M	4.45B	0.2182
HLN Haleon Plc Adr	9.53	44.47B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	16.31	18.83B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	293.12	13.43B	2.99B	1.21B	1.13B	25.06

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-15-25	Downgrade	Jefferies	Buy → Hold
Apr-15-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-14-25	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
Sep-09-24	Initiated	Leerink Partners	Market Perform
Aug-08-24	Downgrade	CapitalOne	Overweight → Equal Weight
Jan-17-24	Initiated	Craig Hallum	Buy
Dec-14-23	Initiated	Wells Fargo	Overweight
Nov-09-23	Initiated	Jefferies	Buy
Sep-28-23	Initiated	JMP Securities	Mkt Outperform
Sep-02-22	Initiated	CapitalOne	Overweight
Apr-22-22	Initiated	Piper Sandler	Overweight
Sep-30-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Jun-17-20	Initiated	Northland Capital	Outperform
Jul-10-19	Resumed	Credit Suisse	Neutral
Mar-27-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Feb-25-19	Upgrade	H.C. Wainwright	Sell → Neutral
Jan-24-19	Upgrade	JP Morgan	Underweight → Neutral
Nov-07-18	Downgrade	Credit Suisse	Outperform → Neutral
Nov-07-18	Downgrade	JP Morgan	Neutral → Underweight
Jul-23-18	Initiated	H.C. Wainwright	Sell
May-09-18	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jan-05-18	Downgrade	BofA/Merrill	Buy → Underperform
Dec-06-17	Downgrade	Mizuho	Buy → Neutral
Jul-21-17	Downgrade	JP Morgan	Overweight → Neutral
May-03-17	Initiated	Wells Fargo	Outperform
Apr-07-17	Reiterated	Mizuho	Buy
Feb-22-17	Reiterated	Barclays	Equal Weight
Nov-04-16	Reiterated	Mizuho	Buy
Oct-24-16	Reiterated	Wedbush	Neutral
Oct-10-16	Reiterated	Mizuho	Buy
Sep-27-16	Reiterated	WallachBeth	Hold

View All

Ironwood Pharmaceuticals Inc Stock (IRWD) Latest News

02:29 AM

What drives Ironwood Pharmaceuticals Inc. stock priceFree Advanced Stock Screener Access - jammulinksnews.com

02:29 AM

Jul 20, 2025

What analysts say about Ironwood Pharmaceuticals Inc. stockExceptional stock performance - PrintWeekIndia

Jul 20, 2025

Jul 19, 2025

Is Ironwood Pharmaceuticals Inc. a good long term investmentBreakout profit opportunities - jammulinksnews.com

Jul 19, 2025

Ironwood Pharmaceuticals Inc. Stock Analysis and ForecastTriple-digit returns - jammulinksnews.com

Jul 19, 2025

Jul 17, 2025

How the Irritable Bowel Syndrome (IBS) Treatment Market Will - openPR.com

Jul 17, 2025

Jul 15, 2025

How Ironwood Pharmaceuticals Inc. stock performs during market volatilityTop Gaining Low Risk Assets - Newser

Jul 15, 2025

What makes Ironwood Pharmaceuticals Inc. stock price move sharplyFast Moving Stock Alerts - Newser

Jul 15, 2025

Why Ironwood Pharmaceuticals Inc. stock attracts strong analyst attentionHigh Confidence Trade Setups - Newser

Jul 15, 2025

Jul 14, 2025

Endometriosis Pain Pipeline 2025: FDA Updates, Therapy Innovations, And Clinical Trial Landscape Analysis By Delveinsight Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, Abbvie/Neurocrine - Menafn.com

Jul 14, 2025

Jul 10, 2025

Ironwood Pharmaceuticals appoints KPMG as new auditor, dismisses EY By Investing.com - Investing.com Nigeria

Jul 10, 2025

Ironwood Pharmaceuticals appoints KPMG as new auditor, dismisses EY - Investing.com

Jul 10, 2025

Jul 03, 2025

Investor Network: Ironwood Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Jul 03, 2025

Jun 30, 2025

Ironwood Pharmaceuticals, Inc.(NasdaqGS: IRWD) added to Russell 3000E Index - MarketScreener

Jun 30, 2025

Jun 25, 2025

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Held Back By Insufficient Growth Even After Shares Climb 28% - simplywall.st

Jun 25, 2025

Jun 12, 2025

Ironwood Pharma Elects Directors at Annual Meeting - TipRanks

Jun 12, 2025

Jun 06, 2025

Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report? - Yahoo Finance

Jun 06, 2025

Jun 05, 2025